Status:
COMPLETED
Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis
Lead Sponsor:
GlaxoSmithKline
Conditions:
Viral Hepatitis Vaccines
Hepatitis A
Eligibility:
All Genders
1-70 years
Brief Summary
The purpose of this study is to determine the seroprevalence of Hepatitis A Virus (HAV), Varicella-Zoster virus (VZV), Cytomegalovirus (CMV), Herpes Simplex (HSV) and Bordetella pertussis (BP)infectio...
Detailed Description
In order to document the epidemiological changes in the sero-prevalence of Hepatitis A, Human simplex virus (1 and 2), Varicella-Zoster virus and Cytomegalovirus infections, we propose to conduct a po...
Eligibility Criteria
Inclusion
- • Previously enrolled subjects aged \>= 1 to 70 years for National Health and Nutrition Survey 2006 in Mexico, with previously obtained informed consent
Exclusion
- Information required for the study is not available or incomplete.
- Inadequate or insufficient serum sample to detect viral agents required for the study.
- Serum sample wrongly identified.
Key Trial Info
Start Date :
March 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
3658 Patients enrolled
Trial Details
Trial ID
NCT01160081
Start Date
March 1 2010
End Date
September 1 2010
Last Update
January 25 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Cuernavaca, Morelos, Mexico